A new Northwestern Medicine study publishing in Nature Medicine suggests a promising alternative to previous attempts to ...

A UTA, University of California–San Francisco study explores why some nerve cells are more vulnerable to neurodegeneration ...

A new study suggests that women who use a popular hormonal menopause treatment later in life may be at a higher risk of developing Alzheimer’s disease.

For more than three decades, scientists have been racing to stop Alzheimer's disease by removing amyloid beta plaques—sticky ...

Menopause hormonal therapy found linked to Alzheimer’s risk - Researchers hope findings could help optimise menopausal ...

Researchers at Northwestern University have made a breakthrough in identifying a way for Alzheimer's disease to be treated ...

The results of a new study show that suppressing KCTD20, which responds to the neurotransmitter glutamate, activates a mechanism for expelling tau proteins.

The neurotransmitter glutamate is essential for regulating everything from mood to memory, but it can also encourage a toxic buildup of protein, which can contribute to Alzheimer's and related ...

"Studies have shown that vulnerability to Alzheimer's-related changes in the brain increase in women from pre- to ...

After Eli Lilly and Biogen’s setbacks in developing O-GlaNAcase (OGA) inhibitors for Alzheimer’s disease, Asceneuron has now ...

Researchers identified a gene that seems to help slow brain aging in women, and studied links between hormone therapy, ...

A special edition of the journal Science focuses on women's health, including links between estrogen and dementia, at a time ...